BNP Paribas Funds Health Care Innovators Privilege Capitalisation/  LU0823417224  /

The Fund is actively managed and as such may invest in securities that are not included in the index which is MSCI World Health Care 10/40 (NR). The Benchmark is used for performance comparison only. The Fund is not benchmark constrained and its performance may derivate significantly from that of the benchmark. The Fund seeks to increase the value of its assets over the medium term by investing in shares issued worldwide by companies which innovate or benefit from healthcare innovation including but not limited to advances in genetic sequencing, drug delivery, miniaturization, bio-compatible materials, haptics and information technology in the healthcare field. Environmental, social and governance (ESG) criteria contribute to, but are not a determining factor in, the manager's decision making.

The Fund is actively managed and as such may invest in securities that are not included in the index which is MSCI World Health Care 10/40 (NR). The Benchmark is used for performance comparison only. The Fund is not benchmark constrained and its performance may derivate significantly from that of the benchmark.